Phase II Dog Lymphoma Trial Confirms Monepantel Clinical Benefit
171211_Lymphoma Trial Result_(clean)
171211_Lymphoma Trial Result_(clean)
171129_Results of AGM
171201_Trading Halt Request
171129_ AGM Presentation
171123_Improved potency of MPL analogues_clean
17113_MPL4_US_New drugs patented for cancer_(clean)
New cancer treatment available for dogs with lymphoma